TSIEX09:	Distribution of Subjects by Study Treatment Lot; Safety Analysis Set (Study jjcs - core)					
 	Active Study Agent 	Active Study Agent 	Active Study Agent 	 	
Study Treatment 	Xanomeline High Dose 	Xanomeline Low Dose 	Combined 	Placebo 	
  Lot, n (%) 	N=53 	N=73 	N=126 	N=59 	
Xanomeline lots 	 	 	 	 	
XXX-YYY-ZZZ-002 	30 (56.6%) 	31 (42.5%) 	61 (48.4%) 	0 	
XXX-YYY-ZZZ-003 	26 (49.1%) 	28 (38.4%) 	54 (42.9%) 	0 	
XXX-YYY-ZZZ-004 	20 (37.7%) 	38 (52.1%) 	58 (46.0%) 	0 	
XXX-YYY-ZZZ-005 	25 (47.2%) 	29 (39.7%) 	54 (42.9%) 	0 	
 	 	 	 	 	
Placebo lots 	 	 	 	 	
XXX-YYY-ZZZ-002 	0 	0 	0 	32 (54.2%) 	
XXX-YYY-ZZZ-003 	0 	0 	0 	28 (47.5%) 	
XXX-YYY-ZZZ-004 	0 	0 	0 	33 (55.9%) 	
XXX-YYY-ZZZ-005 	0 	0 	0 	32 (54.2%) 	

Note: Subjects may be counted in multiple lots, if applicable. 	
Note: Subjects may be counted in multiple lots, if applicable.	
Note: Subjects may be counted in multiple lots, if applicable.	
Note: Subjects may be counted in multiple lots, if applicable.	
Note: Subjects may be counted in multiple lots, if applicable.